Already a DIA Member? Sign in. Not a member? Join.

Iniciar sesión

¿Ha olvidado su ID de usuario? or ¿Ha olvidado su contraseña?

Not a Member?

Create Account and Join

Boston Convention and Exhibition Center

23 jun 2013 8:30 a.m. - 27 jun 2013 12:45 p.m.

415 Summer Street, , Boston, MA 02210 , USA

DIA 2013 49th Annual Meeting: Advancing Therapeutic Innovation and Regulatory Science

Session Chair(s)

Mark C. Hegarty, JD

Mark C. Hegarty, JD

Partner/Attorney

Shook, Hardy & Bacon L.L.P., United States

Learning Objective : Identify the civil and criminal liability risks of conducting clinical trials through case studies; Describe the sponsor's and CRO's exposure to regulatory liability for failure to properly monitor research; Identify what types of clinical trial misconduct could give rise to a criminal prosecution; Discuss recent trends as to liability.

Speaker(s)

John M. Isidor, JD

Panelist

John M. Isidor, JD

Human Subject Protection Consulting, LLC, United States

Chief Executive Officer

Jeffrey N. Gibbs, JD

Panelist

Jeffrey N. Gibbs, JD

Hyman Phelps & McNamara, PC, United States

Director

Kate Gallin Heffernan, FFPM

Contestant

Kate Gallin Heffernan, FFPM

Verrill Dana LLP, United States

Counsel

David  Forster, JD, MA

Contestant

David Forster, JD, MA

WCG, United States

Chief Compliance Officer

Marc B. Wilenzick, JD

Contestant

Marc B. Wilenzick, JD

ViS Research Institute, United States

Head, Stakeholder Engagement

¿Tiene una cuenta?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.